Rothschild Asset Management Has Trimmed Lilly Eli & Co (LLY) Position; Integral Derivatives Has Trimmed Hon (Put) (HON) Stake

May 26, 2018 - By Linda Rogers

Eli Lilly and Company (NYSE:LLY) Logo

Rothschild Asset Management Inc decreased Lilly Eli & Co (LLY) stake by 4.5% reported in 2017Q4 SEC filing. Rothschild Asset Management Inc sold 26,734 shares as Lilly Eli & Co (LLY)’s stock declined 11.06%. The Rothschild Asset Management Inc holds 567,771 shares with $47.95M value, down from 594,505 last quarter. Lilly Eli & Co now has $84.48B valuation. The stock increased 0.07% or $0.06 during the last trading session, reaching $82.77. About 2.34 million shares traded. Eli Lilly and Company (NYSE:LLY) has declined 10.19% since May 26, 2017 and is downtrending. It has underperformed by 21.74% the S&P500.

Integral Derivatives Llc decreased Hon (Put) (HON) stake by 54.44% reported in 2017Q4 SEC filing. Integral Derivatives Llc sold 9,200 shares as Hon (Put) (HON)’s stock declined 5.96%. The Integral Derivatives Llc holds 7,700 shares with $1.18 million value, down from 16,900 last quarter. Hon (Put) now has $112.53B valuation. The stock decreased 0.28% or $0.42 during the last trading session, reaching $150.66. About 1.93M shares traded. Honeywell International Inc. (NYSE:HON) has risen 15.94% since May 26, 2017 and is uptrending. It has outperformed by 4.39% the S&P500.

Among 21 analysts covering Honeywell International Inc. (NYSE:HON), 17 have Buy rating, 0 Sell and 4 Hold. Therefore 81% are positive. Honeywell International Inc. had 97 analyst reports since July 30, 2015 according to SRatingsIntel. On Thursday, October 6 the stock rating was initiated by Robert W. Baird with “Outperform”. The stock has “Hold” rating by S&P Research on Tuesday, October 20. As per Tuesday, July 25, the company rating was maintained by Credit Suisse. The stock of Honeywell International Inc. (NYSE:HON) earned “Buy” rating by Cowen & Co on Tuesday, September 12. Barclays Capital maintained Honeywell International Inc. (NYSE:HON) rating on Monday, April 18. Barclays Capital has “Equal-Weight” rating and $109 target. Jefferies maintained the shares of HON in report on Tuesday, August 22 with “Buy” rating. The rating was maintained by Jefferies on Sunday, January 28 with “Buy”. The firm has “Buy” rating by Oppenheimer given on Monday, April 30. Citigroup maintained it with “Buy” rating and $170 target in Monday, October 9 report. The company was maintained on Wednesday, August 16 by Morgan Stanley.

Analysts await Honeywell International Inc. (NYSE:HON) to report earnings on July, 20. They expect $2.00 earnings per share, up 11.11% or $0.20 from last year’s $1.8 per share. HON’s profit will be $1.49 billion for 18.83 P/E if the $2.00 EPS becomes a reality. After $1.95 actual earnings per share reported by Honeywell International Inc. for the previous quarter, Wall Street now forecasts 2.56% EPS growth.

Integral Derivatives Llc increased Wyn (Call) (NYSE:WYN) stake by 39,900 shares to 47,000 valued at $5.45 million in 2017Q4. It also upped Axp (Call) (NYSE:AXP) stake by 7,800 shares and now owns 15,200 shares. Feye (Put) (NASDAQ:FEYE) was raised too.

Since February 14, 2018, it had 0 insider buys, and 2 sales for $874,731 activity. Deily Linnet F had sold 2,886 shares worth $426,291 on Wednesday, February 14. Another trade for 2,868 shares valued at $448,440 was made by PARDO JAIME CHICO /FA on Monday, February 26.

Another recent and important Honeywell International Inc. (NYSE:HON) news was published by Seekingalpha.com which published an article titled: “Honeywell declares war on fixed costs” on May 22, 2018.

Investors sentiment decreased to 1.11 in Q4 2017. Its down 0.03, from 1.14 in 2017Q3. It fall, as 42 investors sold HON shares while 490 reduced holdings. 154 funds opened positions while 439 raised stakes. 531.30 million shares or 5.59% less from 562.75 million shares in 2017Q3 were reported. Conning Incorporated has 27,931 shares for 0.14% of their portfolio. Glg Ltd Liability Corp invested 0.87% of its portfolio in Honeywell International Inc. (NYSE:HON). Fukoku Mutual Life Insurance reported 3,350 shares. Fiduciary Finance Services Of The Southwest Tx has 1.93% invested in Honeywell International Inc. (NYSE:HON). Moreover, Btim Corporation has 0.32% invested in Honeywell International Inc. (NYSE:HON) for 144,374 shares. Fagan Assocs, New York-based fund reported 6,441 shares. 53,095 are owned by Stonebridge Cap Advisors Ltd Liability Corporation. Fort Washington Invest Incorporated Oh reported 0.42% stake. Salem Invest Counselors reported 0.52% in Honeywell International Inc. (NYSE:HON). Outfitter Advisors Ltd has 1,350 shares. Waverton Investment holds 531,435 shares. Cue Fincl Gp Inc invested in 0.74% or 7,301 shares. Reinhart Prtnrs, a Wisconsin-based fund reported 3,115 shares. Northstar Group Inc has invested 0.23% in Honeywell International Inc. (NYSE:HON). King Wealth Mgmt Grp Inc Limited Liability Com has 2,432 shares.

Since December 11, 2017, it had 0 insider buys, and 11 selling transactions for $48.49 million activity. LILLY ENDOWMENT INC sold 200,000 shares worth $17.64M. $65,790 worth of Eli Lilly and Company (NYSE:LLY) shares were sold by Zakrowski Donald A. Another trade for 3,000 shares valued at $237,600 was sold by Smiley Joshua L. 9,625 shares were sold by Simmons Jeffrey N, worth $780,780 on Thursday, February 1. Mahony Susan also sold $1.81 million worth of Eli Lilly and Company (NYSE:LLY) shares.

Among 22 analysts covering Eli Lilly and Company (NYSE:LLY), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Eli Lilly and Company had 103 analyst reports since July 23, 2015 according to SRatingsIntel. Jefferies maintained Eli Lilly and Company (NYSE:LLY) on Tuesday, January 16 with “Buy” rating. The rating was maintained by Leerink Swann on Monday, May 2 with “Outperform”. As per Wednesday, July 26, the company rating was downgraded by Leerink Swann. As per Friday, October 13, the company rating was maintained by Barclays Capital. Atlantic Securities downgraded the stock to “Neutral” rating in Friday, November 25 report. SunTrust maintained the stock with “Buy” rating in Friday, October 27 report. The firm earned “Buy” rating on Thursday, July 14 by Jefferies. BMO Capital Markets maintained Eli Lilly and Company (NYSE:LLY) on Thursday, February 1 with “Underperform” rating. As per Thursday, October 12, the company rating was maintained by Piper Jaffray. Morgan Stanley maintained it with “Equal-Weight” rating and $90 target in Tuesday, November 21 report.

Rothschild Asset Management Inc increased Conocophillips (NYSE:COP) stake by 118,040 shares to 1.31M valued at $71.92M in 2017Q4. It also upped Ishares Tr (IWN) stake by 6,379 shares and now owns 16,497 shares. Deere & Co (NYSE:DE) was raised too.

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: Bizjournals.com which released: “Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs” on May 10, 2018, also Streetinsider.com with their article: “Lilly (LLY) Says Taltz Received First US FDA Approval for Label Update to Include Data for Psoriasis Involving Genital …” published on May 22, 2018, 247Wallst.com published: “Major Pharma Short Sellers Grow More Selective” on May 25, 2018. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: Streetinsider.com and their article: “Lilly (LLY) to Acquire AurKa Pharma for $110M Upfront, Plus up to $465M in Milestones” published on May 14, 2018 as well as Streetinsider.com‘s news article titled: “Lilly (LLY) Says Galcanezumab Met Primary Endpoint in Phase 3 Study for Prevention of Episodic Cluster Headache” with publication date: May 15, 2018.

Analysts await Eli Lilly and Company (NYSE:LLY) to report earnings on July, 24. They expect $1.34 earnings per share, up 20.72% or $0.23 from last year’s $1.11 per share. LLY’s profit will be $1.37 billion for 15.44 P/E if the $1.34 EPS becomes a reality. After $1.34 actual earnings per share reported by Eli Lilly and Company for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Eli Lilly and Company (NYSE:LLY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts